Pricing Log in Create free account
Friday 6 November 2026 Export ALTO’s income statement to Excel — free account

Alto Ingredients, Inc.

ALTO Basic Materials Specialty Chemicals

Alto Ingredients, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $917.9 million, down 4.90% from fiscal 2024.

Revenue
+12.5%
EPS
+200.0%
Free cash flow
+1,443.9%
Total debt
−48.9%

Quarter to June 2026, against a year earlier

3.84 0.17 +4.63%
Market cap
$284.7M
P/E
5.4×
Fwd P/E
9.7×
Dividend yield
—
F-score
7/9
Altman Z
0.70
Beneish M
−2.81
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Insider Decisions last twelve months

Bought, $m 0.36
Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — 1 — — 1 1 — —
Sell — — — — — — — — — — — —
Insider Ownership 2.85%

Capital & Financial Ratios $m

Size
Market Cap 284.68
Revenue ttm 943.33
Net income ttm 51.99
Free cash flow ttm 49.94
Net debt Q 32.33
Valuation
P/E 5.35
Forward P/E 9.69
Price / sales 0.29
Forward P/S Powerpack
Price / FCF 5.51
Price / book 1.06
Financial health
Current ratio Q 3.19 (at or above 1.5: strong)
Debt / equity Q 0.23 (at or below 0.5: strong)
Interest coverage Q 4.40
Growth
Revenue growth Q +12.48% (above 0%: growing)
Operating income growth Q +206.30% (above 0%: growing)
EPS, this year +197.92% (at or above 15%: strong)
EPS, next year A −20.98% (below 0%: weak)
Revenue, next year A +5.32%
EPS, past 5 yrs —
EPS, next 5 yrs A +46.20% (at or above 15%: strong)

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 0.3×, against a ten-year median of 0.2×; over the ten years it ranged from 0.1× in 2023 to 0.6× in 2021.
P/S against its own 10 years 79.24%
10-year low 10-year high
P/B against its own 10 years 77.74%
10-year low 10-year high
EV/Sales against its own 10 years 80.23%
10-year low 10-year high
EV/FCF against its own 10 years 6.32%
10-year low 10-year high

Dividends

Yield
—
Annual rate
—
Payout ratio
—

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 48 40 26 28
Receivables 59 58 55 68
Inventory 53 50 62 52
Other 10 5 13 13
169 153 156 161
2023 2024 2025 Q'26
Payables 21 20 15 24
ST’ Debt — — 17 —
Other 20 8 6 5
65 58 59 50

Compound Annual Growth %

10y 5y 3y
Sales (2.57%) 0.46% (11.75%)
Cash Flow 0.00% (28.66%) 29.85%
Earnings 0.00% 0.00% 0.00%
Book Value (4.07%) (3.71%) (7.32%)

Earnings Trends EPS, adjusted, against the consensus

Q3 FY26 Estimate 0.07 Actual 0.16

Earnings per share against the consensus, by quarter
Quarter Estimate Reported Result
Q4 FY25 0.02 0.19 Beat by 0.17
Q1 FY26 −0.08 0.05 Beat by 0.13
Q2 FY26 0.09 0.15 Beat by 0.06
Q3 FY26 0.07 0.16 Beat by 0.09
Q4 FY26 0.12 — Reports 3 March 2027

EPS $

Mar Jun Sep Dec Year
’26 0.05 0.15 — — —
’25 (0.16) (0.15) 0.19 0.28 0.16
’24 (0.17) (0.05) (0.04) (0.57) (0.82)
’23 (0.18) 0.10 (0.05) (0.26) (0.40)
’22 (0.04) 0.29 (0.39) (0.46) (0.60)
’21 0.06 0.11 (0.05) 0.49 0.61
’20 (0.47) 0.27 0.24 (0.30) (0.28)
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 225 246 — — —
’25 227 218 241 232 918
’24 241 236 252 236 965
’23 314 317 318 274 1,223
’22 308 362 337 328 1,336
’21 219 298 306 385 1,208
’20 311 212 205 169 897
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 4 28 — — —
’25 (18) (1) 23 10 13
’24 1 (14) 19 (10) (4)
’23 (23) 10 23 12 22
’22 11 10 (19) 4 6
’21 (4) 8 (24) 46 27
’20 27 19 30 (4) 72
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 3 18 — — —
’25 (19) (1) 21 8 9
’24 (3) (18) 18 (11) (14)
’23 (33) 2 16 7 (8)
’22 9 2 (34) (8) (32)
’21 (9) 9 (12) 23 10
’20 26 17 28 4 75
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Jun ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue 1,625 1,632 1,515 1,425 897 1,208 1,336 1,223 965 918 943 (6.1%) 967 977 1,010 +3.2%
Gross margin, % 3.35 0.36 (1.00) (0.70) 5.89 5.61 (2.06) 1.28 1.01 3.80 6.84 +0.4 pt
EBT 1 (38) (68) (101) (17) 48 (40) (28) (59) 13 51 +41.9%
EBT margin, % 0.03 (2.35) (4.52) (7.11) (1.93) 3.94 (2.97) (2.28) (6.09) 1.39 5.45 +1.4 pt
Net income 2 (38) (68) (101) (17) 46 (42) (28) (59) 13 52 +27.2%
Per share, $
Per share, $ Revenue 38.52 38.19 34.94 30.07 15.31 16.99 18.56 16.68 13.14 12.32 12.48 (11.9%)
Earnings 0.00 (0.85) (1.42) (1.90) (0.28) 0.62 (0.60) (0.40) (0.82) 0.16 0.68 n/m
Cash flow 0.88 0.85 0.04 (0.66) 1.22 0.38 0.08 0.30 (0.05) 0.18 0.86 (16.3%)
Capex (0.45) (0.49) (0.35) (0.07) 0.06 (0.23) (0.52) (0.40) (0.15) (0.06) (0.20) (19.9%)
Free cash flow 0.43 0.37 (0.31) (0.73) 1.28 0.15 (0.44) (0.10) (0.19) 0.12 0.66 (13.5%)
Book value 9.92 8.98 7.36 4.79 5.05 4.86 4.28 3.81 3.06 3.29 3.44 (11.5%)
Shares, m 42 43 43 47 59 71 72 73 73 75 75 +6.5%
Valuation, ×
Valuation, × P/E 0.00 0.00 0.00 0.00 0.00 7.76 0.00 0.00 0.00 16.94 5.35 2.5
P/S 0.26 0.12 0.02 0.02 0.35 0.28 0.16 0.16 0.12 0.23 0.29 0.2
P/B 0.99 0.51 0.12 0.14 1.07 0.99 0.68 0.70 0.51 0.88 1.06 0.7
EV/Sales 0.34 0.24 0.16 0.18 0.41 0.26 0.17 0.19 0.18 0.29 0.34 0.2
EV/FCF 30.48 24.83 (17.82) (7.41) 4.89 30.50 (7.16) (31.28) (12.13) 30.99 6.49 4.6
Cash, $m
Cash, $m Operating cash flow 37 37 2 (31) 72 27 6 22 (4) 13 65 (10.8%)
Capex (19) (21) (15) (3) 3 (16) (38) (30) (11) (5) (15) (14.7%)
Free cash flow 18 16 (14) (35) 75 10 (32) (8) (14) 9 50 (7.9%)
Balance, $m
Balance, $m Working capital 156 113 (63) 72 127 160 121 103 95 97 110 (5.2%)
Net debt 135 192 205 225 49 (24) 18 34 53 53 32 (9.8%)
Shareholders’ equity 418 384 319 227 296 345 308 280 225 245 260 (5.8%)
Returns, %
Returns, % ROA 0.02 (5.07) (8.92) (14.18) (3.01) 9.19 (8.90) (6.28) (14.08) 3.06 12.84 +3.0 pt
ROIC 2.66 (2.78) (6.15) (10.33) 1.78 7.79 (11.77) (4.75) (11.60) 1.54 7.62 (1.1) pt
ROE 0.04 (9.04) (17.51) (33.02) (6.26) 13.79 (13.12) (9.96) (23.88) 5.13 21.69 +5.1 pt
People
People Employees 500 560 510 500 370 417 439 460 393 390 — (2.7%)
Revenue/emp, $m 3.25 2.91 2.97 2.85 2.42 2.90 3.04 2.66 2.46 2.35 — (3.5%)
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Alto Ingredients, Inc. vs peers in Specialty Chemicals (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
ASPN Aspen Aerogels, Inc. $428.2M — (loss-making) — (loss-making) +16.66% (above 0%: growing) n/m −93.09% (below 0%: shrinking) 24.15% (8.36%) Compare
MNTK Montauk Renewables, Inc. $343.0M 38.8× 16.6× +19.71% (above 0%: growing) n/m +60.35% (above 0%: growing) 100.00% (0.14%) Compare
GEVO Gevo, Inc. $301.6M — (loss-making) — (loss-making) +7.11% (above 0%: growing) n/m −167.47% (below 0%: shrinking) 42.58% (369.25%) Compare
ALTO Alto Ingredients, Inc. $284.7M 5.4× 9.7× +12.48% (above 0%: growing) n/m +1,443.92% (above 0%: growing) 6.77% 3.51%
ASPI ASP Isotopes Inc. $263.7M — (loss-making) — (loss-making) +327.63% (above 0%: growing) n/m −182.92% (below 0%: shrinking) 28.89% (667.48%) Compare
FF FutureFuel Corp. $236.9M — (loss-making) — (loss-making) +120.69% (above 0%: growing) n/m +4,245.38% (above 0%: growing) 19.08% 14.29% Compare
OEC Orion S.A. $235.7M — (loss-making) — (loss-making) +4.86% (above 0%: growing) n/m +64.87% (above 0%: growing) 19.20% 4.82% Compare
CMT Core Molding Technologies Inc $186.3M 25.6× 44.8× +54.42% (above 0%: growing) −18.18% (below 0%: shrinking) −3,170.52% (below 0%: shrinking) 14.83% 1.76% Compare
HDSN Hudson Technologies, Inc. $172.1M — (loss-making) 33.2× −19.71% (below 0%: shrinking) −82.14% (below 0%: shrinking) +43.42% (above 0%: growing) 24.91% 5.47% Compare
Median of peers $250.3M — 33.2× +18.19% — −24.83% 24.53% 0.81%

All 61 Specialty Chemicals stocks →

Pay and ownership Proxy statement filed 30 April 2026

Ownership

Directors and executive officers, together 4.28% of Common
Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more. Read the proxy statement

Alto Ingredients, Inc. (ALTO) Latest News

5 Nov

Impact 3 · · The Motley Fool transcript
Impact 3 · · Moby
Impact 3 · · GuruFocus.com

4 Nov

Impact 3 · · MarketBeat transcript
Impact 3 · · Zacks
Impact 3 · · Associated Press
Impact 3 · · GlobeNewswire

29 Oct

Impact 3 · · Zacks

24 Aug

Impact 3 ·

17 Aug

Impact 3 ·

14 Aug

Impact 3 ·

13 Aug

Impact 3 · · The Motley Fool transcript

11 Aug

Impact 3 ·

6 Aug

Impact 4 ·
Impact 3 ·

5 Aug

Impact 3 ·
Impact 3 · · MarketBeat transcript
Impact 3 ·

27 Jul

Impact 4 ·

20 Jul

Impact 4 ·

16 Jul

Impact 3 ·

13 Jul

Impact 3 ·

10 Jul

Impact 3 ·

9 Jul

Impact 3 ·

6 Jul

Impact 3 ·

2 Jul

Impact 4 ·

29 Jun

Impact 4 ·
Impact 3 ·

26 Jun

Impact 3 ·

22 Jun

Impact 3 · · Zacks
stockrow.com/ALTO · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com